These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18458244)

  • 1. Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis.
    Thomassin-Naggara I; Bazot M; Daraï E; Callard P; Thomassin J; Cuenod CA
    Radiology; 2008 Jul; 248(1):148-59. PubMed ID: 18458244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors.
    Thomassin-Naggara I; Daraï E; Cuenod CA; Rouzier R; Callard P; Bazot M
    J Magn Reson Imaging; 2008 Jul; 28(1):111-20. PubMed ID: 18581400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of dynamic contrast-enhanced MRI in characterizing complex ovarian tumors.
    Li HM; Qiang JW; Ma FH; Zhao SH
    J Ovarian Res; 2017 Jan; 10(1):4. PubMed ID: 28088245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semi-quantitative contrast-enhanced MR analysis of indeterminate ovarian tumours: when to say malignancy?
    Mansour SM; Saraya S; El-Faissal Y
    Br J Radiol; 2015 Sep; 88(1053):20150099. PubMed ID: 26083260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.
    Buadu LD; Murakami J; Murayama S; Hashiguchi N; Sakai S; Masuda K; Toyoshima S; Kuroki S; Ohno S
    Radiology; 1996 Sep; 200(3):639-49. PubMed ID: 8756909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination--pilot study.
    Taylor SA; Punwani S; Rodriguez-Justo M; Bainbridge A; Greenhalgh R; De Vita E; Forbes A; Cohen R; Windsor A; Obichere A; Hansmann A; Rajan J; Novelli M; Halligan S
    Radiology; 2009 May; 251(2):369-79. PubMed ID: 19276323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters.
    Bali MA; Metens T; Denolin V; Delhaye M; Demetter P; Closset J; Matos C
    Radiology; 2011 Nov; 261(2):456-66. PubMed ID: 21852570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors.
    Jia WR; Chai WM; Tang L; Wang Y; Fei XC; Han BS; Chen M
    Eur J Radiol; 2014 Jul; 83(7):1098-1105. PubMed ID: 24794865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced cardiac MR imaging in the detection of reduced coronary flow velocity reserve.
    Barmeyer AA; Stork A; Muellerleile K; Tiburtius C; Schofer AK; Heitzer TA; Hofmann T; Adam G; Meinertz T; Lund GK
    Radiology; 2007 May; 243(2):377-85. PubMed ID: 17456867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study.
    Thomassin-Naggara I; Balvay D; Aubert E; Daraï E; Rouzier R; Cuenod CA; Bazot M
    Eur Radiol; 2012 Apr; 22(4):738-45. PubMed ID: 22105841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is dynamic gadolinium enhancement needed in MR imaging for the preoperative assessment of scaphoidal viability in patients with scaphoid nonunion?
    Donati OF; Zanetti M; Nagy L; Bode B; Schweizer A; Pfirrmann CW
    Radiology; 2011 Sep; 260(3):808-16. PubMed ID: 21712471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
    Dong Y; Liu Q
    J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity.
    Horsthuis K; Lavini C; Bipat S; Stokkers PC; Stoker J
    Radiology; 2009 May; 251(2):380-7. PubMed ID: 19401571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of bone marrow angiogenesis in patients with acute myeloid leukemia by using contrast-enhanced MR imaging with clinically approved iron oxides: initial experience.
    Matuszewski L; Persigehl T; Wall A; Meier N; Bieker R; Kooijman H; Tombach B; Mesters R; Berdel WE; Heindel W; Bremer C
    Radiology; 2007 Jan; 242(1):217-24. PubMed ID: 17116730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.
    Kim SA; Cho N; Ryu EB; Seo M; Bae MS; Chang JM; Moon WK
    Radiology; 2014 Mar; 270(3):699-707. PubMed ID: 24126372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors.
    Li HM; Feng F; Qiang JW; Zhang GF; Zhao SH; Ma FH; Li YA; Gu WY
    Abdom Radiol (NY); 2018 Nov; 43(11):3132-3141. PubMed ID: 29556691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy.
    van Rijswijk CS; Geirnaerdt MJ; Hogendoorn PC; Taminiau AH; van Coevorden F; Zwinderman AH; Pope TL; Bloem JL
    Radiology; 2004 Nov; 233(2):493-502. PubMed ID: 15459325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between benign and malignant colon tumors using fast dynamic gadolinium-enhanced MR colonography; a feasibility study.
    Achiam MP; Andersen LP; Klein M; Løgager V; Chabanova E; Thomsen HS; Rosenberg J
    Eur J Radiol; 2010 Jun; 74(3):e45-50. PubMed ID: 19419830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.